Detalles de la búsqueda
1.
A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial.
Int J Cancer
; 150(11): 1889-1904, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35262190
2.
MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.
Br J Cancer
; 120(4): 387-397, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30739911
3.
A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control.
Cell Commun Signal
; 16(1): 66, 2018 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30305100
4.
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.
Target Oncol
; 17(4): 407-431, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35906513
5.
Use of LoopDeelab during the COVID-19 Pandemic: An Innovative Device for Field Diagnosis.
Viruses
; 14(9)2022 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36146869
6.
NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells.
J Exp Clin Cancer Res
; 38(1): 158, 2019 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30979377
7.
Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial.
Cancers (Basel)
; 11(12)2019 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31766357
Resultados
1 -
7
de 7
1
Próxima >
>>